Margaret Anderson Joins Deloitte With a Focus on Health Consulting – Press release | Deloitte US has been added to your bookmarks.
Margaret Anderson Joins Deloitte With a Focus on Health Consulting
WASHINGTON, Sept. 18, 2017 — Deloitte announced today that Margaret Anderson has joined its federal health practice as a managing director for Deloitte Consulting LLP. In this role, she will be working across federal health, nonprofit and the health care and life science sectors to help advance solutions to challenges that stand in the way of improved health outcomes for patients.
“Margaret is a known leader in the health community, serving on numerous initiatives designed to improve patient outcomes,” said Kevin Brault, principal, Deloitte & Touche and federal health sector leader. “Her time at FasterCures, as well as her close work with other major health organizations, such as the National Institutes of Health and the Food and Drug Administration, offers valuable experience to support our clients and our efforts to drive improved patient care and outcomes.”
Anderson most recently was the executive director of FasterCures, a Washington-based center of the Milken Institute. FasterCures focuses on spurring cross-sector collaboration, cultivating a culture of innovation and engaging patients as partners.
“Throughout my career, I’ve worked to develop strategies and solutions that will really make a difference in people’s lives,” said Anderson. “I am excited to continue doing this in my role at Deloitte and look forward to working with the federal health practice to address challenges in innovative ways that will help improve the health of citizens nationwide.”
She currently serves on the boards of the Advancing Cures Today (Act) for the National Institutes of Health (NIH), the Melanoma Research Alliance and the Asthma and Allergy Foundation. She is also on the editorial board of Life Science Leader magazine.
Additionally, Anderson is a founding board member and past-president of the Alliance for a Stronger FDA. She was also a founding member of NIH’s National Center for Advancing Translational Sciences Advisory Council and Cures Acceleration Network Review Board. She has served on a number of national health-related boards and committees, including National Health Council board of directors; board of United for Medical Research; FDA's Science Looking Forward Committee; Parker Institute for Immunotherapy Policy Committee; and the National Academy of Medicine's Forum on Drug Discovery, Development and Translation.
Prior to joining FasterCures in 2004, Anderson was the deputy director and a team leader in the Center on AIDS & Community Health at the Academy for Educational Development, where she led public health projects for the Centers for Disease Control and Prevention (CDC) and private foundations. She was program director at the Society for Women’s Health Research and was a health science analyst at the American Public Health Association, where she managed a programmatic portfolio on HIV/AIDS and other sexually transmitted diseases, infectious diseases, women’s health and public health infrastructure issues.
Anderson holds a Bachelor of Arts degree in government and politics from the University of Maryland and a Master of Science degree in technology and public policy from George Washington University.
Deloitte provides industry-leading audit, consulting, tax and advisory services to many of the world’s most admired brands, including 80 percent of the Fortune 500 and more than 6,000 private and middle market companies. Our people work across more than 20 industry sectors to deliver measurable and lasting results that help reinforce public trust in our capital markets, inspire clients to make their most challenging business decisions with confidence, and help lead the way toward a stronger economy and a healthy society.